Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men
| Status: | Archived |
|---|---|
| Conditions: | Obesity Weight Loss, Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2010 |
An Open-label Dose Finding Study Followed by a Parallel Group, Randomized, Double-blind Study to Evaluate the Safety, Tolerability and Pharmacodynamics of 12 Week BGS649 Treatment in Obese, Hypogonadotropic Hypogonadal Men
This study is designed as a 2-part study, with Part 1 being open-label to best determine the
appropriate dose levels to use in Part 2, which has a randomized, double-blind, placebo
controlled design. The study aims to assess the safety and tolerability of BGS649, and
determine whether or not BGS649 is able to normalize testosterone levels and improve
insulin sensitivity in obese, hypogonadotropic hypogonadal (OHH) men
We found this trial at
4
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials